 In both arms, patients demonstrating at least 20 reduction of blasts in bone marrow based on total cellularity and percent blasts after course 1 may receive 1 additional course of induction therapy between days 35-60 in the absence of disease progression or unacceptable toxicity. Patients achieving CR or CRp after 1 or 2 courses of induction therapy proceed to consolidation therapy. 